A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT07104721
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-08-04Est. Completion: 2026-08-04
Enrollment target: 18 participants Locations- The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Other microbiome trials you might be interested in
Systemic Lupus Erythematosus
This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy an…
Anniston, United StatesEst. completion Jun 29, 2027
Antiphospholipid Syndrome (APS)
Antiphospholipid syndrome (APLS) is a rare pathology characterized by the association of thrombotic (arterial, venous) o…
Rouen, FranceEst. completion Oct 16, 2027
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030